Prototype posterior chamber phakic IOL - 35 year follow up.
Spyridon Doumazos1, Aikaterini Barlampa1, Stylianos A Kandarakis1
1First Department of Ophthalmology, National and Kapodistrian University of Athens, "G. Gennimatas" General Hospital of Athens, Greece.
American Journal of Ophthalmology Case Reports
|June 27, 2024
Summary
This case study details the successful removal of a rare, 35-year-old prototype posterior chamber phakic intraocular lens (PC-pIOL) in a highly myopic patient. The procedure restored excellent visual acuity, demonstrating a viable surgical option for managing long-term PC-pIOL complications.
Area of Science:
- Ophthalmology
- Intraocular Lens Technology
- Surgical Case Reports
Background:
- Presents a rare case of a prototype posterior chamber phakic intraocular lens (PC-pIOL) implanted 35 years ago.
- Addresses management challenges in a highly myopic patient with bilateral mature cataracts and phacodonesis.
Observation:
- A 64-year-old male with a 35-year-old PC-pIOL presented with severe vision loss (20/200 OD, NLP OS).
- The unique, bow-tie shaped PC-pIOL with an anteriorly extending component was successfully extracted.
- Pars plana vitrectomy (PPV) with lens fragmentation was performed on the right eye, leaving the patient aphakic.
Findings:
- The rare PC-pIOL was removed without difficulty.
- Post-operative aphakia following PPV was a successful management strategy.
- Excellent final corrected visual acuity of 20/25 was achieved in the operated eye one month post-surgery.
Implications:
- Highlights the long-term clinical manifestations and management of rare, older-generation phakic intraocular lenses.
- Demonstrates that aphakia after complete vitrectomy is a viable alternative to IOL implantation in complex cases.
- Provides insights into the surgical removal of long-implanted, unusual intraocular lens designs.
Keywords:
Cataract complicationsFyodorovLensectomyPosterior chamber-Phakic IOLPrototype phakic IOLVitrectomyMore Related Videos
Related Concept Videos
Glaucoma: Overview
538
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
538
Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
Focusing of Light in the Eye
2.7K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
2.7K
Angle Closure Glaucoma: Treatment
471
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
471


